Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review (English)
- New search for: Khunti, Kamlesh
- New search for: Gomes, Marilia B.
- New search for: Pocock, Stuart
- New search for: Shestakova, Marina V.
- New search for: Pintat, Stéphane
- New search for: Fenici, Peter
- New search for: Hammar, Niklas
- New search for: Medina, Jesús
- New search for: Khunti, Kamlesh
- New search for: Gomes, Marilia B.
- New search for: Pocock, Stuart
- New search for: Shestakova, Marina V.
- New search for: Pintat, Stéphane
- New search for: Fenici, Peter
- New search for: Hammar, Niklas
- New search for: Medina, Jesús
In:
Diabetes, Obesity and Metabolism
;
20
, 2
;
427-437
;
2018
- Article (Journal) / Electronic Resource
-
Title:Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
-
Contributors:Khunti, Kamlesh ( author ) / Gomes, Marilia B. ( author ) / Pocock, Stuart ( author ) / Shestakova, Marina V. ( author ) / Pintat, Stéphane ( author ) / Fenici, Peter ( author ) / Hammar, Niklas ( author ) / Medina, Jesús ( author )
-
Published in:Diabetes, Obesity and Metabolism ; 20, 2 ; 427-437
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2018-02-01
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 20, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 231
-
Diabetes, Obesity and Metabolism| 2018
- 233
-
Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors)Nunez, Derek J. / D'Alessio, David et al. | 2018
- 238
-
Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose‐lowering interventionsRoussel, Ronan / Steg, Philippe Gabriel / Mohammedi, Kamel / Marre, Michel / Potier, Louis et al. | 2018
- 245
-
The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetesGingras, Véronique / Taleb, Nadine / Roy‐Fleming, Amélie / Legault, Laurent / Rabasa‐Lhoret, Rémi et al. | 2018
- 257
-
Therapeutic application of GPR119 ligands in metabolic disordersYang, Jin Won / Kim, Hyo Seon / Choi, Yong‐Won / Kim, Young‐Mi / Kang, Keon Wook et al. | 2018
- 270
-
PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular diseasePage, Michael M. / Watts, Gerald F. et al. | 2018
- 283
-
A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteersKostic, Ana / King, Thomas Alexander / Yang, Feng / Chan, Kuo‐Chen / Yancopoulos, George D. / Gromada, Jesper / Harp, Joyce B. et al. | 2018
- 292
-
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40‐week extension of the GUARD randomized studyHan, Sang Youb / Yoon, Sun Ae / Han, Byoung Geun / Kim, Sung Gyun / Jo, Young‐Il / Jeong, Kyung Hwan / Oh, Kook‐Hwan / Park, Hyeong Cheon / Park, Sun‐Hee / Kang, Shin‐Wook et al. | 2018
- 301
-
Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative surveyBerard, Lori / Bonnemaire, Mireille / Mical, Marie / Edelman, Steve et al. | 2018
- 309
-
Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population‐based retrospective cohort studyWan, Eric Yuk Fai / Fong, Daniel Yee Tak / Fung, Colman Siu Cheung / Yu, Esther Yee Tak / Chin, Weng Yee / Chan, Anca Ka Chun / Lam, Cindy Lo Kuen et al. | 2018
- 319
-
Beneficial long‐term antidiabetic actions of N‐ and C‐terminally modified analogues of apelin‐13 in diet‐induced obese diabetic miceParthsarathy, Vadivel / Hogg, Christopher / Flatt, Peter R. / O'Harte, Finbarr P. M. et al. | 2018
- 328
-
Evaluation of the specific effects of intranasal glucagon on glucose production and lipid concentration in healthy men during a pancreatic clampDash, Satya / Xiao, Changting / Stahel, Priska / Koulajian, Khajag / Giacca, Adria / Lewis, Gary F. et al. | 2018
- 335
-
Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trialYang, Wenying / Min, Kyungwan / Zhou, Zhiguang / Li, Ling / Xu, XiangJin / Zhu, Dalong / Venkateshwar Rao, A. / Murthy, Laxminarayanappa Sreenivasa / Zhang, Nianxian / Li, Ivy et al. | 2018
- 344
-
Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational studyPersson, Frederik / Nyström, Thomas / Jørgensen, Marit E. / Carstensen, Bendix / Gulseth, Hanne L. / Thuresson, Marcus / Fenici, Peter / Nathanson, David / Eriksson, Jan W. / Norhammar, Anna et al. | 2018
- 352
-
Efficacy and pharmacokinetics of subcutaneous exendin (9‐39) in patients with post‐bariatric hypoglycaemiaCraig, Colleen M. / Liu, Li‐fen / Nguyen, Thi / Price, Candice / Bingham, Justus / McLaughlin, Tracey L. et al. | 2018
- 362
-
The bile acid‐sequestering resin sevelamer eliminates the acute GLP‐1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetesBrønden, Andreas / Albér, Anders / Rohde, Ulrich / Gasbjerg, Lærke S. / Rehfeld, Jens F. / Holst, Jens J. / Vilsbøll, Tina / Knop, Filip K. et al. | 2018
- 370
-
Sodium‐glucose cotransporter‐2 inhibition improves incretin sensitivity of pancreatic β‐cells in people with type 2 diabetesAhn, Chang Ho / Oh, Tae Jung / Kwak, Soo Heon / Cho, Young Min et al. | 2018
- 378
-
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetesSeino, Yutaka / Terauchi, Yasuo / Osonoi, Takeshi / Yabe, Daisuke / Abe, Nobuyuki / Nishida, Tomoyuki / Zacho, Jeppe / Kaneko, Shizuka et al. | 2018
- 389
-
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and GermanyKhunti, Kamlesh / Godec, Thomas R. / Medina, Jesús / Garcia‐Alvarez, Laura / Hiller, Josh / Gomes, Marilia B. / Cid‐Ruzafa, Javier / Charbonnel, Bernard / Fenici, Peter / Hammar, Niklas et al. | 2018
- 400
-
Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK‐1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjectsCrutchlow, Michael F. / Palcza, John S. / Mostoller, Kate M. / Mahon, Chantal D. / Barbour, April M. / Marcos, Michael C. / Xu, Yang / Watkins, Elaine / Morrow, Linda / Hompesch, Marcus et al. | 2018
- 409
-
Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1cGallwitz, Baptist / Dagogo‐Jack, Samuel / Thieu, Vivian / Garcia‐Perez, Luis‐Emilio / Pavo, Imre / Yu, Maria / Robertson, Kenneth E. / Zhang, Nan / Giorgino, Francesco et al. | 2018
- 419
-
Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetesJohansen, Rakel F. / Søndergaard, Esben / Linnebjerg, Helle / Garhyan, Parag / Lam, Eric C. Q. / Porksen, Niels / Jacober, Scott J. / Nielsen, Søren et al. | 2018
- 427
-
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic reviewKhunti, Kamlesh / Gomes, Marilia B. / Pocock, Stuart / Shestakova, Marina V. / Pintat, Stéphane / Fenici, Peter / Hammar, Niklas / Medina, Jesús et al. | 2018
- 438
-
Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non‐alcoholic fatty liver disease: A prospective randomized controlled pilot studyShibuya, Takashi / Fushimi, Nobutoshi / Kawai, Miyuka / Yoshida, Yohei / Hachiya, Hiroki / Ito, Shun / Kawai, Hiromi / Ohashi, Noritsugu / Mori, Akihiro et al. | 2018
- 443
-
The effect of exercise on sleep in adults with type 1 diabetesReddy, Ravi / El Youssef, Joseph / Winters‐Stone, Kerri / Branigan, Deborah / Leitschuh, Joseph / Castle, Jessica / Jacobs, Peter G. et al. | 2018
- 448
-
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)Roussel, Ronan / d'Emden, Michael C. / Fisher, Miles / Ampudia‐Blasco, F. Javier / Stella, Peter / Bizet, Florence / Cali, Anna M. G. / Wysham, Carol H. et al. | 2018
- 453
-
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative studyKadowaki, Takashi / Inagaki, Nobuya / Kondo, Kazuoki / Nishimura, Kenichi / Kaneko, Genki / Maruyama, Nobuko / Nakanishi, Nobuhiro / Gouda, Maki / Iijima, Hiroaki / Watanabe, Yumi et al. | 2018
- 458
-
Effects of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta‐analysis of randomized controlled trialsZhao, Yumo / Xu, Lubin / Tian, Dongli / Xia, Peng / Zheng, Hua / Wang, Li / Chen, Limeng et al. | 2018
- 463
-
Metformin extended‐release versus immediate‐release: An international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetesAggarwal, Naresh / Singla, Anuj / Mathieu, Chantal / Montanya, Eduard / Pfeiffer, Andreas F. H. / Johnsson, Eva / Zhao, June / Iqbal, Nayyar / Bailey, Clifford et al. | 2018
- 468
-
Comparative effectiveness of once‐weekly glucagon‐like peptide‐1 receptor agonists with regard to 6‐month glycaemic control and weight outcomes in patients with type 2 diabetesUnni, Sudhir / Wittbrodt, Eric / Ma, Junjie / Schauerhamer, Marisa / Hurd, Jeff / Ruiz‐Negrón, Natalia / McAdam‐Marx, Carrie et al. | 2018
- 474
-
Primary sulphonylurea therapy in a newborn with transient neonatal diabetes attributable to a paternal uniparental disomy 6q24 (UPD6)Neumann, Uta / Bührer, Christoph / Blankenstein, Oliver / Kühnen, Peter / Raile, Klemens et al. | 2018
- i
-
Cover Image, Volume 20, Issue 2Seino, Yutaka / Terauchi, Yasuo / Osonoi, Takeshi / Yabe, Daisuke / Abe, Nobuyuki / Nishida, Tomoyuki / Zacho, Jeppe / Kaneko, Shizuka et al. | 2018